Clinical Trial Update: Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial assessed hydroxychloroquine prophylaxis among COVID-19 household contacts using remote ECG monitoring; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Bryn Mawr Hospital | Conditions: Covid19, Hydroxychloroquine | Phase 4 | Status: COMPLETED